Evidence map›Paper›PMID 16047089›Full record

GuidelineJournal of genetic counseling2005

Genetic counseling for fragile x syndrome: updated recommendations of the national society of genetic counselors.

Allyn McConkie-Rosell, Brenda Finucane, Amy Cronister, Liane Abrams, Robin L Bennett, Barbara J Pettersen

Abstract readPractice Guideline
PubMed Publisher
In one paragraph

Guideline in Journal of genetic counseling, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Identity and Reproductive Aspects in Females with Fragile X Syndrome.Women's health reports (New Rochelle, N.Y.) · 2021
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Development of a fragile X syndrome (FXS) knowledge scale: towards a modified multidimensional measure of informed choice for FXS population carrier screening.Health expectations : an international journal of public participation in health care and health policy · 2015
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Newborn screening and cascade testing for FMR1 mutations.American journal of medical genetics. Part A · 2013
    Article
  17. A new approach to primary ovarian insufficiency.Obstetrics and gynecology clinics of North America · 2012
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Allyn McConkie-RosellDuke University Medical Center, Durham, North Carolina 27710, USA. mccon006@mc.duke.edu
Brenda Finucane
Amy Cronister
Liane Abrams
Robin L Bennett
Barbara J Pettersen

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

These recommendations describe the minimum standard criteria for genetic counseling and testing of individuals and families with fragile X syndrome, as well as carriers and potential carriers of a fragile X mutation. The original guidelines (published in 2000) have been revised, replacing a stratified pre- and full mutation model of fragile X syndrome with one based on a continuum of gene effects across the full spectrum of FMR1 CGG trinucleotide repeat expansion. This document reviews the molecular genetics of fragile X syndrome, clinical phenotype (including the spectrum of premature ovarian failure and fragile X-associated tremor-ataxia syndrome), indications for genetic testing and interpretation of results, risks of transmission, family planning options, psychosocial issues, and references for professional and patient resources. These recommendations are the opinions of a multicenter working group of genetic counselors with expertise in fragile X syndrome genetic counseling, and they are based on clinical experience, review of pertinent English language articles, and reports of expert committees. These recommendations should not be construed as dictating an exclusive course of management, nor does use of such recommendations guarantee a particular outcome. The professional judgment of a health care provider, familiar with the facts and circumstances of a specific case, will always supersede these recommendations.

Indexed as

AllelesBrainCognition DisordersDNA Mutational AnalysisFemaleFragile X Messenger Ribonucleoprotein 1Fragile X SyndromeGene Expression RegulationGenetic CounselingHumansMalePhenotypePoint MutationPregnancyPregnancy ComplicationsPrenatal DiagnosisFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.